Nurtec ODT 75 MG tablet 8S
Ended Awarded
- Contract number
- SPE2DB26FP0VY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,528
Award facts
- Contract value 100% obligated
- $5,528.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,528.32 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packaging) on November 6, 2025, with an ultimate completion date of November 7, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026.
NURTEC ODT is a migraine treatment medication, and this delivery order reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting the Defense Health Agency and other federal military healthcare systems. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains an extensive portfolio of federal medical supply contracts covering a broad range of therapeutic domains, including specialty medications, vaccines, and medical devices. The DLA Troop Support Medical contract serves as the primary vehicle enabling AmerisourceBergen to fulfill federal pharmaceutical procurement requirements globally for military healthcare programs, with the broader federal pharmaceutical market anticipated to see multiple awards across regional pharmaceutical prime vendor contracts in coming years.
Quick answers
Who was awarded contract SPE2DB26FP0VY?
SPE2DB26FP0VY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FP0VY worth?
The government has obligated $5,528 on SPE2DB26FP0VY.
Is contract SPE2DB26FP0VY an order under another contract?
Yes. SPE2DB26FP0VY is a delivery order under SPE2DB22D3010, an indefinite delivery contract.
Was contract SPE2DB26FP0VY competed?
The extent of competition for SPE2DB26FP0VY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award